Low PSA level possibly associated with long term risk of prostate cancer in young men, aged 40-49: Correlation with the number of affected first degree relatives in high risk families

Author： Valeri A.   Cormier L.   Moineau M.P.   Azzouzi R.   Joulin V.   Doucet L.   Mangin P.   Cussenot O.   Morin J.F.   Fourmier G.  

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.2, Iss.1, 2003-02, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low levels of PSA predict long-term risk of prostate cancer: results from the Baltimore longitudinal study of aging

By Schroder F.H.   Wildhagen M.F.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 462-462

Elsevier

Access to resources Recommend Favorite

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination

By Uzzo R.G.   Pinover W.H.   Horwitz E.M.   Parlanti A.   Mazzoni S.   Raysor S.   Mirchandani I.   Greenberg R.E.   Pollack A.   Hanks G.E.   Watkins-Bruner D.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 754-759

Elsevier

Access to resources Recommend Favorite

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

IGF, PSA, glandular hyperplasia and cancer risk in the prostate

By Barrass B.J.R.   Persad R.A.   Gillatt D.A.   Neal D.E.   Hamdy F.C.   Oliver S.E.   Gunnell D.J.   Donovan J.L.   Peters T.J.   Holly J.M.P.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite